Clinical Trial Update: Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas [Phase 1]

View source ↗

Summary

This document reports a Phase I clinical trial of oral ZIO-101-C for advanced solid tumors and lymphomas, with the trial status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• ZIO-101-C

Snippet

Sponsor: Alaunos Therapeutics | Conditions: Advanced Solid Tumors, Lymphomas | Phase 1 | Status: UNKNOWN